Skip to main content
. 2019 Aug 4;25:400–414.

Table 1. The basic parameters of photoresponses presented as ratios of post- and pretreated values, obtained in “outer segment out” configuration in Ringer’s solution and after 20 min incubation in drug-containing solution (mean ± SEM); * denotes p < 0.05 versus control, & denotes p < 0.05 versus 0.1% DMSO control.

  Light sensitivity Aсtivation rate (A) Turn-off time constant (τoff) Dark current Dominant recovery time constant (τD)
Control
0.99±0.04
0.75±0.06
1.01±0.05
1.06±0.04
1.01±0.05
 
(n=10)
(n=10)
(n=10)
(n=10)
(n=10)
 
 
 
 
 
 
Dopamine (0.1 µM)
0.9±0.06
0.89±0.12
0.83±0.07
0.95±0.04
1.11±0.07
 
(n=12)
(n=12)
(n=12)
(n=12)
(n=11)
 
 
 
 
 
 
Dopamine
0.74±0.07
0.72±0.07
0.97±0.14
1.02±0.07
1.04±0.04
(2.5 µM)
(n=10) *
(n=10)
(n=10)
(n=10)
(n=9)
 
 
 
 
 
 
Dopamine (20 µM)
0.66±0.06
0.57±0.10
0.8±0.11
0.99±0.04
0.92±0.08
 
(n=9) *
(n=9)
(n=9)
(n=9)
(n=8)
Dopamine (50 µM)
0.71±0.04
0.56±0.10
0.66±0.05
1.05±0.02
0.89±0.06
 
(n=7) *
(n=7)
(n=7)
(n=7)
(n=7)
SKF-38,393
0.74±0.04
0.83±0.05
0.90±0.06
1.03±0.02
0.87±0.06
(0.1 µM)
(n=10) *
(n=10)
(n=10)
(n=10)
(n=10)
 
 
 
 
 
 
SKF-38393
0.77±0.04
0.76±0.07
0.93±0.05
1.07±0.03
0.83±0.05
(2.5 µM)
(n=9) *
(n=9)
(n=9)
(n=9)
(n=9)
 
 
 
 
 
 
SKF-38393
0.62±0.05
0.60±0.05
0.72±0.06
1.00±0.02
0.75±0.04
(20 µM)
(n=10) *
(n=10)
(n=10) *
(n=10)
(n=10) *
 
 
 
 
 
 
SKF-38393
0.58±0.08
0.47±0.11
0.64±0.07
1.07±0.04
0.62±0.03
(50 µM)
(n=9) *
(n=9)
(n=9) *
(n=9)
(n=8) *
 
 
 
 
 
 
Quinpirole (2.5 µM)
0.86±0.09
0.85±0.07
1.05±0.11
1.05±0.03
0.98±0.08
 
(n=9)
(n=9)
(n=9)
(n=9)
(n=8)
Quinpirole (20 µM)
0.85±0.08
0.71±0.05
0.96±0.06
1.05±0.03
0.94±0.04
 
(n=10)
(n=10)
(n=10)
(n=10)
(n=9)
Quinpirole (50 µM)
0.74±0.02
0.68±0.05
0.82±0.05
1.11±0.06
0.95±0.03
 
(n=11) *
(n=11)
(n=11)
(n=11)
(n=11)
Control
1.00±0.03
1.11±0.08
1.08±0.10
1.03±0.02
1.11±0.04
(0.1% DMSO)
(n=5)
(n=5)
(n=5)
(n=5)
(n=5)
 
 
 
 
 
 
SKF-83959
0.73±0.02
0.97±0.07
0.78±0.03
1.05±0.03
1.01±0.07
(50 µM) (n=10) & (n=10) (n=10) & (n=10) (n=5)